G49108TO
| Organisms | Evidence |
|---|---|
| Streptococcus pneumoniae | |
| Mus musculus (house mouse) | |
| Saccharomyces cerevisiae (brewer's yeast) | |
| Sus scrofa (pig) | |
| Rattus norvegicus (Norway rat) |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
| B4GALT1 | UDP-Gal |
|
R |
|
R | |
| B4GALT2 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
| B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
| B3GALT5 | UDP-Gal |
|
R |
|
R |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B3GALT5 | UDP-Gal |
|
R |
|
R | |
| B4GALT4 | UDP-Gal |
|
|
|||
| B3GALT1 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
| B4GALNT4 | UDP-GalNAc |
|
R |
|
R | |
| B4GALNT3 | UDP-GalNAc |
|
R |
|
R |
| Pathway Name | Organism |
|---|---|
| Antimicrobial peptides | Sus scrofa |
| Antimicrobial peptides | Rattus norvegicus |
| Antimicrobial peptides | Dictyostelium discoideum |
| Antimicrobial peptides | Bos taurus |
| Antimicrobial peptides | Canis familiaris |
| Antimicrobial peptides | Mus musculus |
| Antimicrobial peptides | Gallus gallus |
| Antimicrobial peptides | Homo sapiens |
| Antimicrobial peptides | Drosophila melanogaster |
| Antimicrobial peptides | Xenopus tropicalis |
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 39054338 | Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV | Wang G | 2024 Jul 25 |
|
| 39199296 | Decoding the Role of O-GlcNAcylation in Hepatocellular Carcinoma | Zhou X | 2024 Jul 25 |
|
| 38953369 | ROK family regulator NagC promotes prodigiosin biosynthesis independent of N -acetylglucosamine in Serratia sp. ATCC 39006 | Liu W | 2024 Jul 24 |
|
| 39043656 | The molecular basis underlying T cell specificity towards citrullinated epitopes presented by HLA-DR4 | Loh TJ | 2024 Jul 23 |
|
| 39002130 | Crimean-Congo hemorrhagic fever survivors elicit protective non-neutralizing antibodies that target 11 overlapping regions on glycoprotein GP38 | Shin OS | 2024 Jul 23 |
|
| 39042673 | Molecular mechanisms of proteoglycan-mediated semaphorin signaling in axon guidance | Nourisanami F | 2024 Jul 23 |
|
| 39044290 | Chronic rapid eye movement sleep deprivation aggravates the pathogenesis of Alzheimer’s disease by decreasing brain O-GlcNAc cycling in mice | Kim DY | 2024 Jul 23 |
|
| 38856634 | Broad Protection against Invasive Fungal Disease from a Nanobody Targeting the Active Site of Fungal β‐1,3‐Glucanosyltransferases | Redrado-Hernández S | 2024 Jul 22 |
|
| 39051333 | Humanization of Pan-HLA-DR mAb 44H10 Hinges on Critical Residues in the Antibody Framework | Kassardjian A | 2024 Jul 16 |
|
| 38889725 | H19 influenza A virus exhibits species-specific MHC class II receptor usage | Karakus U | 2024 Jul 10 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025